49 Einträge gefunden

1. Younger patients with chronic myeloid leukemia do well in spite of poor prognostic indicators: results from the randomized CML study IV

   1. Kalmanti, Lida
   2. Saussele, Susanne
   3. Lauseker, Michael
   4. Proetel, Ulrike
   5. Müller, Martin C
   6. Hanfstein, Benjamin
   7. Schreiber, Annette

   2014 - Forschungsinformationssystem des UKE
2. Deep molecular response is reached by the majority of patients treated with imatinib, predicts survival, and is achieved more quickly by optimized high-dose imatinib: results from the randomized CML-study IV

   1. Hehlmann, Rüdiger
   2. Müller, Martin C
   3. Lauseker, Michael
   4. Hanfstein, Benjamin
   5. Fabarius, Alice
   6. Schreiber, Annette
   7. Proetel, Ulrike

   2014 - Forschungsinformationssystem des UKE
3. Postallogeneic monitoring with molecular markers detected by pretransplant next-generation or Sanger sequencing predicts clinical relapse in patients with myelodysplastic/myeloproliferative neoplasms

   1. Fu, Yuewen
   2. Schroeder, Thomas
   3. Zabelina, Tatiana
   4. Badbaran, Anita
   5. Bacher, Ulrike
   6. Kobbe, Guido
   7. Ayuketang, Francis Ayuk

   2014 - Forschungsinformationssystem des UKE
4. ETV6 rearrangements are recurrent in myeloid malignancies and are frequently associated with other genetic events.

   1. Haferlach, Claudia
   2. Bacher, Ulrike
   3. Schnittger, Susanne
   4. Alpermann, Tamara
   5. Zenger, Melanie
   6. Kern, Wolfgang
   7. Haferlach, Torsten

   2012 - Forschungsinformationssystem des UKE
5. Multilineage dysplasia does not influence prognosis in CEBPA-mutated AML, supporting the WHO proposal to classify these patients as a unique entity.

   1. Bacher, Ulrike
   2. Schnittger, Susanne
   3. Macijewski, Katja
   4. Grossmann, Vera
   5. Kohlmann, Alexander
   6. Alpermann, Tamara
   7. Kowarsch, Andreas

   2012 - Forschungsinformationssystem des UKE
6. Frequency and prognostic impact of the aberrant CD8 expression in 5,523 patients with chronic lymphocytic leukemia.

   1. Kern, Wolfgang
   2. Bacher, Ulrike
   3. Haferlach, Claudia
   4. Alpermann, Tamara
   5. Dicker, Frank
   6. Schnittger, Susanne
   7. Haferlach, Torsten

   2012 - Forschungsinformationssystem des UKE
7. Monoclonal B-cell lymphocytosis is closely related to chronic lymphocytic leukaemia and may be better classified as early-stage CLL.

   1. Kern, Wolfgang
   2. Bacher, Ulrike
   3. Haferlach, Claudia
   4. Dicker, Frank
   5. Alpermann, Tamara
   6. Schnittger, Susanne
   7. Haferlach, Torsten

   2012 - Forschungsinformationssystem des UKE
8. Prognoses of MDS subtypes RARS, RCMD and RCMD-RS are comparable but cytogenetics separates a subgroup with inferior clinical course.

   1. Bacher, Ulrike
   2. Kern, Wolfgang
   3. Alpermann, Tamara
   4. Schnittger, Susanne
   5. Haferlach, Claudia
   6. Haferlach, Torsten

   2012 - Forschungsinformationssystem des UKE
9. Molecular analyses of 15,542 patients with suspected BCR-ABL1-negative myeloproliferative disorders allow to develop a stepwise diagnostic workflow.

   1. Schnittger, Susanne
   2. Bacher, Ulrike
   3. Eder, Christiane
   4. Dicker, Frank
   5. Alpermann, Tamara
   6. Grossmann, Vera
   7. Kohlmann, Alexander

   2012 - Forschungsinformationssystem des UKE - frei zugänglich
10. Use of CBL exon 8 and 9 mutations in diagnosis of myeloproliferative neoplasms and myelodysplastic/myeloproliferative disorders: an analysis of 636 cases.

    1. Schnittger, Susanne
    2. Bacher, Ulrike
    3. Alpermann, Tamara
    4. Reiter, Andreas
    5. Ulke, Madlen
    6. Dicker, Frank
    7. Eder, Christiane

    2012 - Forschungsinformationssystem des UKE - frei zugänglich
11. Development and validation of a real-time quantification assay to detect and monitor BRAFV600E mutations in hairy cell leukemia.

    1. Schnittger, Susanne
    2. Bacher, Ulrike
    3. Haferlach, Torsten
    4. Wendland, Nicole
    5. Ulke, Madlen
    6. Dicker, Frank
    7. Grossmann, Vera

    2012 - Forschungsinformationssystem des UKE
12. Amount of bone marrow blasts is strongly correlated to NPM1 and FLT3-ITD mutation rate in AML with normal karyotype.

    1. Haferlach, Torsten
    2. Bacher, Ulrike
    3. Alpermann, Tamara
    4. Haferlach, Claudia
    5. Kern, Wolfgang
    6. Schnittger, Susanne

    2012 - Forschungsinformationssystem des UKE
13. TET2 deletions are a recurrent but rare phenomenon in myeloid malignancies and are frequently accompanied by TET2 mutations on the remaining allele.

    1. Bacher, Ulrike
    2. Weissmann, Sandra
    3. Kohlmann, Alexander
    4. Schindela, Sonja
    5. Alpermann, Tamara
    6. Schnittger, Susanne
    7. Kern, Wolfgang

    2012 - Forschungsinformationssystem des UKE
14. Clinical impact of FLT3 mutation load in acute promyelocytic leukemia with t(15;17)/PML-RARA.

    1. Schnittger, Susanne
    2. Bacher, Ulrike
    3. Haferlach, Claudia
    4. Kern, Wolfgang
    5. Alpermann, Tamara
    6. Haferlach, Torsten

    2011 - Forschungsinformationssystem des UKE - frei zugänglich
15. Recent advances in diagnosis, molecular pathology and therapy of chronic myelomonocytic leukaemia.

    1. Bacher, Ulrike
    2. Haferlach, Torsten
    3. Schnittger, Susanne
    4. Kreipe, Hans
    5. Kröger, Nicolaus

    2011 - Forschungsinformationssystem des UKE
16. A copy number repeat polymorphism in the transactivation domain of the CEPBA gene is possibly associated with a protective effect against acquired CEBPA mutations: an analysis in 1135 patients with AML and 187 healthy controls.

    1. Schnittger, Susanne
    2. Bacher, Ulrike
    3. Eder, Christiane
    4. Lohse, Peter
    5. Haferlach, Claudia
    6. Kern, Wolfgang
    7. Haferlach, Torsten

    2011 - Forschungsinformationssystem des UKE
17. Minimal residual disease diagnostics and chimerism in the post-transplant period in acute myeloid leukemia.

    1. Bacher, Ulrike
    2. Haferlach, Torsten
    3. Fehse, Boris
    4. Schnittger, Susanne
    5. Kröger, Nicolaus

    2011 - Forschungsinformationssystem des UKE - frei zugänglich
18. Molecular diagnostics, targeted therapy, and the indication for allogeneic stem cell transplantation in acute lymphoblastic leukemia.

    1. Oyekunle, Anthony
    2. Haferlach, Torsten
    3. Kröger, Nicolaus
    4. Klyuchnikov, Evgeny
    5. Zander, Axel R.
    6. Schnittger, Susanne
    7. Bacher, Ulrike

    2011 - Forschungsinformationssystem des UKE - frei zugänglich
19. Acute monoblastic/monocytic leukemia and chronic myelomonocytic leukemia share common immunophenotypic features but differ in the extent of aberrantly expressed antigens and amount of granulocytic cells.

    1. Kern, Wolfgang
    2. Bacher, Ulrike
    3. Haferlach, Claudia
    4. Schnittger, Susanne
    5. Haferlach, Torsten

    2011 - Forschungsinformationssystem des UKE
20. Several lymphoma-specific genetic events in parallel can be found in mature B-cell neoplasms.

    1. Bacher, Ulrike
    2. Haferlach, Torsten
    3. Alpermann, Tamara
    4. Kern, Wolfgang
    5. Schnittger, Susanne
    6. Haferlach, Claudia

    2011 - Forschungsinformationssystem des UKE